B-One manufactures artificial joints using proprietary technologies such as AvaTi™ 3D printing and Sapphire GXL™ gradient-crosslinked antioxidant polyethylene. Their products, including total knee and hip replacement systems, aim to enhance patient mobility and improve healthcare economics by providing clinically proven solutions for joint replacement.
Funding
$60.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional artificial joints can suffer from wear and tear, potentially limiting their lifespan and requiring revision surgeries. Existing materials may not always provide optimal biocompatibility or mechanical performance for all patients.
Solution
B-One manufactures artificial joints, including total knee and hip replacement systems, utilizing proprietary technologies to enhance durability and performance. Their AvaTi™ technology employs 3D printing to create customized implants tailored to individual patient anatomy. Sapphire GXL™ gradient-crosslinked antioxidant polyethylene is used to improve wear resistance and biocompatibility, potentially extending the lifespan of the implant. These technologies aim to improve patient mobility and reduce the need for future revision surgeries.
Target Audience
The primary target audience includes orthopedic surgeons and hospitals seeking advanced artificial joint solutions for patients requiring hip or knee replacement.
Features
- AvaTi™ 3D printing technology for customized implant design and manufacturing.
- Sapphire GXL™ gradient-crosslinked antioxidant polyethylene for enhanced wear resistance.
- MOBIO® Total Knee System, leveraging over 30 years of know-how.
- JUVENO® and KOSMO® Femoral Stems for hip replacement.
- PRIMO™ Acetabular System for hip replacement.